00:01
So after the patient has presented
with a certain clinical syndrome,
and we're worried
this could be a tumor,
we want to evaluate that
with imaging.
00:08
And the most common imaging
that's performed for patients
may begin with a CT,
but ends with an MRI of the brain
to really characterize that lesion
comprehensively.
00:20
So the second step
after clinical presentation
is imaging evaluation.
00:25
What types of imaging do we use?
I said CT and MRI.
00:28
And MRI is really the
diagnostic modality of choice,
for evaluating gliomas.
00:33
Conventional MRI will show a mass
like lesion in the brain parenchyma
in the tissue of the brain,
and this should tip us off
to think about tumors
that arise
from the cells in the brain.
00:44
Astrocytomas, oligodendrogliomas,
ependymomas, and others.
00:49
Contrast enhancement is important.
00:51
And we'll talk in
the next few slides
about the benefit of
contrast enhancement
and evaluating the
aggressiveness of tumors.
00:57
Tumors that are growing
more aggressively,
enhanced with contrast more avidly,
and tumors that are often
less aggressive, or of lower grade
typically do not enhance
or more weakly enhance,
more minimally enhanced
with contrast.
01:10
Increasing contrast enhancement
is seen as tumors grow
from grade II, to III, to grade IV.
01:17
Let's look at the prevalence
of contrast enhancement,
and its benefit and value
for evaluating a patient
or a clinical vignette of a patient
who may be presenting with a glioma.
01:28
Contrast enhancement.
01:29
Gadolinium on the scan is present
in 96% of glioblastomas.
01:33
And typically,
this is a ring of enhancement,
as we saw with our
second patient, and second case
at the beginning of this lecture.
01:41
Grade III or Anaplastic gliomas,
we only see contrast enhancement
in about half of those patients
50 to 60%.
01:48
So presence of contrast enhancement
should tip us off
that we could see
a higher grade,
but we don't see that
in all of these grade III
or anaplastic gliomas.
01:57
And then we don't commonly see
contrast enhancement
for lower-grade gliomas.
Only in about 20% of patients.
02:03
And typically, this is not that
ring enhancement pattern,
but a more patchy or heterogeneous
pattern of contrast enhancement.
02:10
So let's look at that.
02:11
Grade I tumors are the least
aggressive, the lowest-grade.
02:15
They're actually uncommon in
adults and more common in children.
02:18
And we'll talk about those
in the next couple of slides.
02:21
They do enhance with contrast,
and this defies our rule
of increased enhancement
with increasing grade
because we commonly see
avid contrast enhancement
for grade I tumors like this
pilocytic astrocytoma,
of the left optic nerve.
02:35
Of the infiltrating gliomas,
we see that pattern
of contrast enhancement.
02:40
Grade II, low-grade gliomas
typically do not enhance.
02:45
Anaplastic gliomas often
homogeneously enhance
or have salt and pepper
punctate enhancement
within the inside of the lesion.
02:52
And what characterizes glioblastomas
is this ring of enhancement
and that should tip us off
that we're looking likely
at a grade IV glioma.